Paradromics Secures FDA Approval to Test Brain Implant in Humans The biotech company Paradromics recently announced a pivotal milestone: full approval from the U.S. Food and Drug Administration to begin clinical trials of its cutting-edge brain implant in human participants. This move marks a significant step forward in the development of brain-computer interfaces (BCIs) that…